Tue | May 28, 2024

Final tests of some COVID-19 vaccines to start next month

Published:Thursday | June 11, 2020 | 2:57 PM
In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren, File)

The first experimental COVID-19 vaccine in the United States is on track to begin a huge study next month to prove if it really can fend off the coronavirus, while hard-hit Brazil is testing a different shot from China.

Where to do crucial, late-stage testing and how many volunteers are needed to roll up their sleeves are big worries for health officials as the virus spread starts tapering off in parts of the world.

Moderna Inc. said Thursday the vaccine it is developing with the National Institutes of Health will be tested in 30,000 people in the US Some will get the real shot and some a dummy shot, as scientists carefully compare which group winds up with the most infections.

With far fewer COVID-19 cases in China, Sinovac Biotech turned to Brazil, the epicentre of Latin America’s outbreak, for at least part of its final testing.

The government of São Paulo announced Thursday that Sinovac will ship enough of its experimental vaccine to test in 9,000 Brazilians starting next month.

If it works, “with this vaccine we will be able to immunise millions of Brazilians,” said São Paulo´s Governor Joao Doria.

Worldwide, about a dozen COVID-19 potential vaccines are in early stages of testing.

The NIH expects to help several additional shots move into those final, large-scale studies this summer, including one made by Oxford University that’s also being tested in a few thousand volunteers in Brazil.

There’s no guarantee any of the experimental shots will pan out.

But if all goes well, “there will be potential to get answers” on which vaccines work by the end of the year, Dr John Mascola, who directs NIH’s vaccine research center, told a meeting of the National Academy of Medicine on Wednesday.

Vaccines train the body to recognise a virus and fight back, and specialists say it’s vital to test shots made in different ways — to increase the odds that at least one kind will work.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.